BESPOKE Study of ctDNA Guided Immunotherapy (BESPOKE IO)

The University of Virginia is conducting a clinical research study for adults ages 18 and over, who have advanced non-small cell lung cancer, melanoma or colorectal cancer who will receive standard of care immunotherapy and will be monitored with Signatera ctDNA testing. This study is observing the clinical care of patients receiving Signatera ctDNA testing and does not require other additional lab tests or clinical procedures to be performed specifically for the study, except for providing informed consent prior to receiving immunotherapy.

Your participation on this study is expected to last approximately 2 years.

Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT04761783

uvacancertrials@hscmail.mcc.virginia.edu